Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Pre-treated Metastatic Nonseminomatous Germ-cell Tumors
NCT02115165Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Jul 2014
- Primary completion
- Apr 2022
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in non-seminomatous germ cell tumor (NSGCT), sponsored by Gustave Roussy. Started Jul 2014; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
non-seminomatous germ cell tumor (NSGCT)
Beyond the preview
Go deeper on NCT02115165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115165.